- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07681180
Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies (EASY-HD)
Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies: EASY-HD Pilot Study
The goal of this prospective pilot study is to learn if the use of virtual reality and/or relaxing soundscapes can help lower anxiety in adult patients undergoing a scheduled coronary angiography or angioplasty as compared to the standard of care. The main questions it aims to answer are:
- The use of non-pharmacological strategies reduces intraprocedural stress and anxiety compared to standard of care
- Reducing anxiety limits the use of pharmacological agents, which increases patient safety.
Researchers will compare the use of relaxing soundscapes or virtual reality to the standard of care to see the effects of these strategies on pain, anxiety and stress.
Participants will:
- listen to relaxing soundscapes, OR experience virtual reality including soundscapes OR standard of care during their procedure,
- Answer pain, anxiety and recovery questionnaires,
- Answer satisfaction questionnaires.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
The EASY-HD project is a prospective, randomized, controlled pilot study to evaluate the effectiveness of immersive nonpharmacological strategies, soundscapes, and virtual reality (VR) on the reduction of intraprocedural anxiety and stress in patients undergoing a scheduled hemodynamic intervention (coronary angiography and/or angioplasty).
Adult patients will be included and randomized into three parallel groups (1:1:1): standard of care alone (control group), standard of care combined with relaxing soundscapes via headphones, or standard of care combined with virtual reality immersion in a soothing environment including sound. The devices will be set up 5 to 10 minutes before the procedure and continued througout.
This minimal-risk study aims to determine the feasibility and potential clinical benefit of these simple, reproducible non-pharmacological approaches to improve patient comfort and possibly reduce the need for hemodynamic sedation.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Michele Jadin
- Telefoonnummer: 4186568711
- E-mail: michele.jadin@criucpq.ulaval.ca
Studie Locaties
-
-
Quebec
-
Québec, Quebec, Canada, G1V 4G5
- IUCPQ
-
Hoofdonderzoeker:
- Olivier F Bertrand, MD, PhD
-
Contact:
- Michele Jadin
- Telefoonnummer: 418-656-8711
- E-mail: michele.jadin@criucpq.ulaval.ca
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Adults, 18 years or older
- Scheduled hemodynamic intervention (coronary angiography and/or angioplasty)
- Patient willing and able to understand the study
- Signed informed consent
Exclusion Criteria:
- Scheduled complex procedure (CTO, structural)
- Severe cognitive or psychiatric disorders
- Major hearing/visual impairment
- Severe motion sickness or history of malaise with Virtual Reality (VR)
- Complaints of nausea or vomiting
- History of epilepsy
- Claustrophobia
- Facial injuries
- In clinical isolation (infection control)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Control
Standard of care analgesic and anxiolytic therapy
|
|
|
Experimenteel: Auditive experience
A pre-defined non-invasive audio experience using relaxing soundscapes via headphones will be used along standard of care pain and anxiety-relief medication (on patient's demand).
|
Auditive distraction therapy
|
|
Experimenteel: Immersion experience
A pre-defined virtual-reality led audiovisual experience will be used along standard of care pain and anxiety-relief medication (on patient's demand).
|
Virtual reality-lead audiovisual experience
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in patient-reported anxiety
Tijdsspanne: Baseline (preprocedural), periprocedural and at one-week follow-up
|
Change from baseline in patient reported anxiety evaluated by anxiety questionnaires Visual Analog Score for anxiety (0 = Not anxious at all - 10 = Extremely anxious) |
Baseline (preprocedural), periprocedural and at one-week follow-up
|
|
Change in patient-reported anxiety
Tijdsspanne: Baseline, Periprocedural, and at one-week follow-up
|
Change from baseline in patient reported anxiety evaluated by anxiety questionnaires State-Trait Anxiety Invetory for Adults - 6 item short form |
Baseline, Periprocedural, and at one-week follow-up
|
|
Change in patient-reported pain
Tijdsspanne: Baseline, periprocedural and at one-week follow-up
|
Change from baseline in patient reported pain evaluated by pain questionnaires Visual Analog Scale for pain (0=No pain - 10 = Worst pain possible) |
Baseline, periprocedural and at one-week follow-up
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Use of analgesic and anxiolytic medications
Tijdsspanne: Within 48 hours before and after the procedure
|
Use vs no-use of analgesic (opioid/non-opioid) and/or anxiolytic medication. If analgesic and/or anxiolytic medication is used, its type, dose and frequency will be registered. |
Within 48 hours before and after the procedure
|
|
Change from baseline in physiological factors associated with pain and anxiety - Heart Rate
Tijdsspanne: Baseline, periprocedural
|
Heart rate (beats per minute)
|
Baseline, periprocedural
|
|
Change from baseline in physiological factors associated with pain and anxiety - Respiratory Rate
Tijdsspanne: Baseline, periprocedural
|
Respiratory rate (breaths per minute)
|
Baseline, periprocedural
|
|
Change from baseline in physiological factors associated with pain and anxiety - Blood Pressure
Tijdsspanne: Baseline, Periprocedural
|
Blood pressure (mmHg)
|
Baseline, Periprocedural
|
|
Incidence of adverse events of interest
Tijdsspanne: Within 10 days of the procedure
|
Patient-reported nausea, dizziness and increased anxiety will be collected
|
Within 10 days of the procedure
|
Andere uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Incidence of adverse cardiac events
Tijdsspanne: Within 10 days of the procedure
|
Within 10 days of the procedure
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- EASY-HD
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .